Ken Kikuchi

Research Assistant Professor

Kyoto Prefectural University of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ken Kikuchi is a Research Assistant Professor at Kyoto Prefectural University of Medicine in Japan. His research primarily focuses on oncological studies, specifically in the areas of rhabdomyosarcoma and neuroblastoma. Recent publications include investigations into the effects of histone deacetylase inhibitors and the role of PAX3-FOXO1 in tumorigenicity and cellular behavior. His work contributes to the development of novel therapeutic strategies for aggressive cancers.

Articles (11)

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Hideki Yoshida

Assistant professor

Kyoto Prefectural University of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ken Kikuchi

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors

The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity.

The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma.

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma

Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma

Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma

Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma

Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma

Collaborators (1)

Hideki Yoshida

Make your next move.